Clinical Trial Update: Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma

View source ↗

Summary

The update discusses using liver stiffness measurement to predict progression of liver fibrosis after transarterial chemoembolization in hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Failure

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Hepatocellular Carcinoma, Liver Failure | Status: UNKNOWN